Phase I trial of NY-ESO-1 TCR-T cell therapy combined with nanoparticulate vaccine but without lymphodepletion for STS
Mikiya Ishihara,Yoshihiro Nishida,Shigehisa Kitano,Akira Kawai,Naozumi Harada,Yoshihiro Miyahara,Hiroyoshi Hattori,Kohichi Takada,Makoto Emori,Shigeki Kakunaga,Makoto Endo,Yoshihiro Matsumoto,Tetsuro Sasada,Eiichi Sato,Tomomi Yamada,Akihiko Matsumine,Yasuhiro Nagata,Shinichi Kageyama,Hiroshi Shiku ANNALS OF ONCOLOGY（2023）
AI 理解论文
溯源树
样例
